Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
8.89M
-
Shares change
-
-588K
-
Total reported value, excl. options
-
$20.5M
-
Value change
-
-$657K
-
Put/Call ratio
-
0.01
-
Number of buys
-
13
-
Number of sells
-
-14
-
Price
-
$2.31
Significant Holders of Equillium, Inc. - COM (EQ) as of Q1 2024
36 filings reported holding EQ - Equillium, Inc. - COM as of Q1 2024.
Equillium, Inc. - COM (EQ) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.89M shares
.
Largest 10 shareholders include Decheng Capital LLC (4.45M shares), TAKEDA PHARMACEUTICAL CO LTD (1.82M shares), VANGUARD GROUP INC (842K shares), Cota Capital Management, LLC (562K shares), RENAISSANCE TECHNOLOGIES LLC (209K shares), GEODE CAPITAL MANAGEMENT, LLC (200K shares), ADAR1 Capital Management, LLC (199K shares), ACADIAN ASSET MANAGEMENT LLC (109K shares), Callan Capital, LLC (99.7K shares), and STATE STREET CORP (52.6K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.